Fallopian tube adhesions

Fallopian tube adhesions are pathological bands of fibrous scar tissue that form between the Fallopian tubes and other pelvic structures, such as the ovaries, uterus, or bowel. This condition is not a molecular target (like a receptor or enzyme) but rather a clinical manifestation of abnormal tissue healing following inflammation, infection (such as pelvic inflammatory disease), or surgical trauma. The formation of these adhesions is driven by a cascade of peritoneal injury, fibrin deposition, and inadequate fibrinolysis, which allows the persistent attachment of adjacent organ surfaces (StatPearls, NIH). Clinically, Fallopian tube adhesions are a primary cause of tubal factor infertility, as they can physically distort or block the tubes, preventing the transport of oocytes and sperm. They also significantly increase the risk of ectopic pregnancy and are a frequent cause of chronic pelvic pain. While there are no pharmacological "drugs" that target adhesions in the traditional sense, therapeutic strategies focus on the surgical removal of tissue (adhesiolysis) and the use of physical barrier agents like hyaluronic acid-based gels to prevent new adhesions from forming during the postoperative healing phase (Mayo Clinic; PubMed).

Other names

Peritubal adhesionsPelvic adhesionsTubal factor infertilityIntra-abdominal adhesionsSynechiae

Mechanical barrier formation to prevent tissue apposition during healing; reduction of fibrin bridge formation.